Pleomorphic adenoma
You don't need to be Editor-In-Chief to add or edit content to WikiDoc. You can begin to add to or edit text on this WikiDoc page by clicking on the edit button at the top of this page. Next enter or edit the information that you would like to appear here. Once you are done editing, scroll down and click the Save page button at the bottom of the page.
| Pleomorphic adenoma Classification and external resources | |
 | |
|---|---|
| Pleomorphic adenoma consists of mixed epithelial (left) and mesenchymal cell components (right). The latter often exhibits myxofibrous appearance and in some instances shows chondromatous differentiation. | |
| ICD-10 | D11. |
| ICD-9 | 210.2 |
| ICD-O: | 8940/0 |
| OMIM | 181030 |
| eMedicine | radio/531 |
| MeSH | D008949 |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Phone:617-632-7753
Contributors: Cafer Zorkun M.D., PhD.
Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [2] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.
Overview
Pleomorphic adenoma is a benign neoplastic tumour of the salivary glands. It is the most common type of salivary gland tumour and the most common tumour of the parotid gland. It derives its name from the architectural pleomorphism (variable appearance) seen by light microscopy. It is also known as "Mixed tumor, salivary gland type", which describes its pleomorphic appearance as opposed to its dual origin from epithelial and myoepithelial elements.[1]
Clinical Presentation
The tumour is usually solitary and presents as a slow growing, painless, firm single nodular mass. Isolated nodules are generally outgrowths of the main nodule rather than a multinodular presentation. It is usually mobile unless found in the palate and can cause atrophy of the mandibular ramus when located in the parotid gland. When found in the parotid tail, it may present as an eversion of the ear lobe. Though it is a benign tumour, pleomorphic adenomas have the capacity to grow to large proportions.
Diagnosis
The diagnosis of salivary gland tumors utilize both histopathological sampling and radiographic studies. Histopathological sampling procedures include fine needle aspiration (FNA) and core needle biopsy (bigger needle comparing to FNA). Both of these procedures can be done in an outpatient setting. Diagnostic imaging techniques for salivary gland tumors include ultrasound, computer tomography (CT) and magnetic resonance imaging (MRI). Fine needle aspiration biopsy (FNA), operated in experienced hands, can determine whether the tumor is malignant in nature with sensitivity around 90%[2][3]. FNA can also distinguish primary salivary tumor from metastatic disease. Core needle biopsy can also be done in outpatient setting. It is more invasive but is more accurate compared to FNA with diagnostic accuracy greater than 97%[4]. Furthermore, core needle biopsy allows more accurate histological typing of the tumor. In terms of imaging studies, ultrasound can determine and characterize superficial parotid tumors. Certain types of salivary gland tumors have certain sonographic characteristics on ultrasound[5]. Ultrasound is also frequently used to guide FNA or core needle biopsy. CT allows direct, bilateral visualization of the salivary gland tumor and provides information about overall dimension and tissue invasion. CT is excellent for demonstrating bony invasion. MRI provides superior soft tissue delineation such as perineural invasion when compared to CT only[6].
Diagnostic Findings
- At US, pleomorphic adenomas are hypoechoic, well-defined, lobulated tumors with posterior acoustic enhancement and may contain calcifications.
- On CT, pleomorphic adenomas are typically smooth, well-marginated tumors. The attenuation values of the mass are usually homogeneous and higher than that of the surrounding gland. Tumor enhancement is variable and can result in a missed diagnosis if delayed images are not acquired (Pleomorphic adenomas are poorly enhancing in the early phase of contrast enhancement, though the amount of enhancement increases over time).
- On MRI, pleomorphic adenomas are usually well-circumscribed, homogeneous masses with low intensity on T1-weighted images and high intensity on T2-weighted images. They commonly have a rim of decreased signal intensity on T2-weighted images. After gadolinium enhancement, the tumors are homogeneously enhancing unless they are large (unlike CT, MRI has no role in delayed imaging).
 MRI: A right parotid pleomorphic adenoma |
 MRI: A right parotid pleomorphic adenoma |
 MRI: A right parotid pleomorphic adenoma |
 MRI: A right parotid pleomorphic adenoma |
 MRI: A right parotid pleomorphic adenoma |
 PET: A right parotid pleomorphic adenoma |
Histology
Histologically, it is highly variable in appearance, even within individual tumours. It is characterized by an admixture of epithelial and myoepithelial elements in a variable background stroma that may be mucoid, myxoid, cartilaginous or hyaline. Epithelial elements may be arranged in duct-like structures, sheets, clumps and/or interlacing strands and consist of polygonal, spindle or stellate-shaped cells (hence pleomorphism). Areas of squamous metaplasia and epithelial pearls may be present. The tumour is usually enveloped by a fibrous capsule of varying thickness and often incomplete. The tumour often extends through these discontinuities but is not a sign of malignant transformation as it does not invade surrounding tissues.
Treatment
Overall, the mainstay of the treatment for salivary gland tumor is surgical resection. Needle biopsy is highly recommended prior to surgery to confirm the diagnosis. More detailed surgical technique and the support for additional adjuvant radiotherapy depends on whether the tumor is malignant or benign. Generally, benign tumors of the parotid gland are treated with superficial or total parotidectomy with the latter being the more commonly practiced due to high incidence of recurrence[7]. The facial nerve should be preserved whenever possible. The benign tumors of the submandibular gland is treated by simple excision with preservation of mandibular branch of the trigeminal nerve, the hypoglossal nerve, and the lingual nerve[8]. Similarly, other benign tumors of minor salivary glands are treated similarly. Malignant salivary tumors usually require wide local resection of the primary tumor. However, if complete resection cannot be achieved, adjuvant radiotherapy should be added to improve local control[9][10]. This surgical treatment has many sequellae such as cranial nerve damage, Frey's syndrome , cosmetic problems, etc.
References
- ↑ Ewa J. Bialek, Wieslaw Jakubowski, Piotr Zajkowski, Kazimierz T. Szopinski, and Antoni Osmolski. US of the Major Salivary Glands: Anatomy and Spatial Relationships, Pathologic Conditions, and Pitfalls. RadioGraphics 2006 26: 745-763.
- ↑ Cohen EG, Patel SG, Lin O, et al (Jun 2004). "Fine-needle aspiration biopsy of salivary gland lesions in a selected patient population". Arch Otolaryngol Head Neck Surg 130 (6): 773–8. doi:10.1001/archotol.130.6.773. PMID 15210562.
- ↑ Batsakis JG, Sneige N, el-Naggar AK (Feb 1992). "Fine-needle aspiration of salivary glands: its utility and tissue effects". Ann Otol Rhinol Laryngol 101 (2 Pt 1): 185–8. PMID 1739267.
- ↑ Wan YL, Chan SC, Chen YL, et al (Oct 2004). "Ultrasonography-guided core-needle biopsy of parotid gland masses". AJNR Am J Neuroradiol 25 (9): 1608–12. PMID 15502149.
- ↑ Białek EJ, Jakubowski W, Karpińska G (Sep 2003). "Role of ultrasonography in diagnosis and differentiation of pleomorphic adenomas: work in progress". Arch Otolaryngol Head Neck Surg 129 (9): 929–33. doi:10.1001/archotol.129.9.929. PMID 12975263.
- ↑ Koyuncu M, Seşen T, Akan H, et al (Dec 2003). "Comparison of computed tomography and magnetic resonance imaging in the diagnosis of parotid tumors". Otolaryngol Head Neck Surg 129 (6): 726–32. doi:10.1016/j.otohns.2003.07.009. PMID 14663442.
- ↑ Stennert E, Guntinas-Lichius O, Klussmann JP, Arnold G (Dec 2001). "Histopathology of pleomorphic adenoma in the parotid gland: a prospective unselected series of 100 cases". Laryngoscope 111 (12): 2195–200. doi:10.1097/00005537-200112000-00024. PMID 11802025.
- ↑ Leonetti JP, Marzo SJ, Petruzzelli GJ, Herr B (Sep 2005). "Recurrent pleomorphic adenoma of the parotid gland". Otolaryngol Head Neck Surg 133 (3): 319–22. doi:10.1016/j.otohns.2005.04.008. PMID 16143173.
- ↑ Ganly I, Patel SG, Coleman M, Ghossein R, Carlson D, Shah JP (Jul 2006). "Malignant minor salivary gland tumors of the larynx". Arch Otolaryngol Head Neck Surg. 132 (7): 767–70. doi:10.1001/archotol.132.7.767. PMID 16847187.
- ↑ Terhaard CH, Lubsen H, Rasch CR, et al (Jan 2005). "The role of radiotherapy in the treatment of malignant salivary gland tumors". Int J Radiat Oncol Biol Phys 61 (1): 103–11. doi:10.1016/j.ijrobp.2004.03.018. PMID 15629600.
See also
- Warthin's tumor - monomorphic adenoma
External links
WikiDoc Research Resources for Pleomorphic adenoma | |
|---|---|
| Articles on Pleomorphic adenoma | Most recent articles on Pleomorphic adenoma • Most cited articles on Pleomorphic adenoma • Review articles on Pleomorphic adenoma • Articles on Pleomorphic adenoma in N Eng J Med, Lancet, BMJ |
| Media (Slides, Video, Images, MP3) on Pleomorphic adenoma | Powerpoint slides on Pleomorphic adenoma • Images of Pleomorphic adenoma • Photos of Pleomorphic adenoma • Podcasts & MP3s on Pleomorphic adenoma • Videos on Pleomorphic adenoma |
| Evidence Based Medicine Regarding Pleomorphic adenoma | Cochrane Collaboration on Pleomorphic adenoma • Bandolier on Pleomorphic adenoma • TRIP on Pleomorphic adenoma |
| Cost Effectiveness of Pleomorphic adenoma | Cost Effectiveness of Pleomorphic adenoma |
| Clinical Trials Involving Pleomorphic adenoma | Ongoing Trials on Pleomorphic adenoma at Clinical Trials.gov • Trial results on Pleomorphic adenoma • Clinical Trials on Pleomorphic adenoma at Google |
| Guidelines / Policies / Government Resources (FDA/CDC) Regarding Pleomorphic adenoma | US National Guidelines Clearinghouse on Pleomorphic adenoma • NICE Guidance on Pleomorphic adenoma • NHS PRODIGY Guidance • FDA on Pleomorphic adenoma • CDC on Pleomorphic adenoma |
| Textbook Information on Pleomorphic adenoma | Books and Textbook Information on Pleomorphic adenoma |
| Pharmacology Resources on Pleomorphic adenoma | Dosing of Pleomorphic adenoma • Drug interactions with Pleomorphic adenoma • Side effects of Pleomorphic adenoma • Allergic reactions to Pleomorphic adenoma • Overdose information on Pleomorphic adenoma • Carcinogenicity information on Pleomorphic adenoma • Pleomorphic adenoma in pregnancy • Pharmacokinetics of Pleomorphic adenoma • |
| Genetics, Pharmacogenomics, and Proteinomics of Pleomorphic adenoma | Genetics of Pleomorphic adenoma • Pharmacogenomics of Pleomorphic adenoma • Proteomics of Pleomorphic adenoma |
| Newstories on Pleomorphic adenoma | Pleomorphic adenoma in the news • Be alerted to news on Pleomorphic adenoma • News trends on Pleomorphic adenoma |
| Commentary on Pleomorphic adenoma | Blogs on Pleomorphic adenoma |
| Patient Resources on Pleomorphic adenoma | Patient resources on Pleomorphic adenoma • Discussion groups on Pleomorphic adenoma • Patient Handouts on Pleomorphic adenoma • Directions to Hospitals Treating Pleomorphic adenoma • Risk calculators and risk factors for Pleomorphic adenoma |
| Healthcare Provider Resources on Pleomorphic adenoma | Symptoms of Pleomorphic adenoma • Causes & Risk Factors for Pleomorphic adenoma • Diagnostic studies for Pleomorphic adenoma • Treatment of Pleomorphic adenoma |
| Continuing Medical Education (CME) Programs on Pleomorphic adenoma | CME Programs on Pleomorphic adenoma |
| International Resources on Pleomorphic adenoma | Pleomorphic adenoma en Espanol • Pleomorphic adenoma en Francais |
| Business Resources on Pleomorphic adenoma | Pleomorphic adenoma in the Marketplace • Patents on Pleomorphic adenoma |
| Informatics Resources on Pleomorphic adenoma | List of terms related to Pleomorphic adenoma |
| ||||
Acknowledgement and Attribution Regarding Sources of Content
Some of the initial content on this page may be incorporated in part from copyleft sources in the public domain including wikis such as Wikipedia and AskDrWiki. Drug information for patients came from the The National Library of Medicine. Infectious disease information may have come from the Centers for Disease Control (CDC). Differential Diagnoses are drawn from clinicians as well as an amalgamation of 3 sources: 1.The Disease Database; 2. Kahan, Scott, Smith, Ellen G. In A Page: Signs and Symptoms. Malden, Massachusetts: Blackwell Publishing, 2004:3; 3. Sailer, Christian, Wasner, Susanne. Differential Diagnosis Pocket. Hermosa Beach, CA: Borm Bruckmeir Publishing LLC, 2002:7 .
